Day: November 28, 2022

PRESS RELEASE: NACON: 2022-23 HALF-YEAR RESULTS

PRESS RELEASE: NACON: 2022-23 HALF-YEAR RESULTS

                                                     Press release Lesquin, 28 November 2022, 18:00hrs 2022-23 HALF-YEAR RESULTS UP 77.5 M€ SALES (+6.2%) 11.1 M€ CURRENT OPERATING PROFIT (+31.4%) 8.4 M€ NET RESULT (+123.5%) 2022-23 YEAR-END RESULTS EXPECTED TO GROW THRIVING PUBLISHING ACTIVITY IN HY2 2022-23 NACON (ISIN FR0013482791) today releases its audited consolidated results for 1st Half Year 2022-23 (from April 1, 2022 to September 30, 2022) as approved by its Board of directors on 28 November 2022. Consolidated in M€ – IFRS 09/2022 09/2021 Change Sales 77.5 73.0 +6.2% Gross margin (1)In % of Sales EBITDA (2)In % of Sales 47.661.4% 25.633.1% 38.052.1% 21.429.3% +25.1% +19.8% Current operating incomeEBITAIn % of Sales Non recurrent items 11.114.,3% (1.3) 8.411.6% (4.0) +31.4% Operating incomeIn % of Sales 9.812.7% 4.56.1% +119.2% Financial...

Continue reading

Avid Promotes Technology Services Executive Deb Sanders to Chief Customer Officer

Avid Promotes Technology Services Executive Deb Sanders to Chief Customer Officer

Sanders’ 25-year career focus on services spans global-scale IT, security and networking businesses with deep experience in service delivery transformation BURLINGTON, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) — Avid® (Nasdaq: AVID) today announced the promotion of technology services executive Deb Sanders to the role of Chief Customer Officer & Senior Vice President to lead worldwide operations for customer success, customer care, advocacy, learning and overall CX, as well as oversee collaboration with the customer-led Avid Community Association. Deb Sanders joined Avid as Vice President of Global Customer Care in 2019 with responsibility for the vision, strategy and tactical plans for the global customer care organization supporting thousands of large media enterprises and hundreds of thousands of creative individuals who rely...

Continue reading

BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022

BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022

Woburn, Nov. 28, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (“Biofrontera” or the “Company”) (NASDAQ: BFRI), announced today that they will be participating in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series to discuss its latest investor presentation on Wednesday, November 30, 2022, at 12:00 PM EST, Monday, December 5, 2022, at 1:00 PM CST, Friday, December 9, 2022 at 12:00 PM EST and Monday, December 19, 2022 at 1:00 PM PST. Biofrontera Inc. welcomes stakeholders, investors, and other individual followers to register and attend these live events. The presentation will feature Prof. Hermann Luebbert, Executive Chairman, Erica Monaco, CEO, and Fred Leffler, CFO. Topics to be covered will include the investor presentation including the latest company news, followed by a live Q&A....

Continue reading

Aleafia Health Successfully Completes TSX Review and Announces Entry into Fifth Province

Aleafia Health Successfully Completes TSX Review and Announces Entry into Fifth Province

Successful completion of TSX listing review Expansion of adult-use portfolio into key fifth province 5 provinces now selling Aleafia’s adult-use products TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) — Further to its previous announcements, Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has completed the TSX delisting review and confirms that the Company satisfies the Toronto Stock Exchange’s requirements for continued listing. Aleafia Health will continue to trade on the TSX without further review at this time. “We are very pleased that the TSX has completed its five-month long review process and the Company is no longer being assessed for potential delisting. Over that time period, Aleafia has demonstrated performance in its key financial metrics,” said Tricia Symmes,...

Continue reading

Dynacor Declares December 2022 Monthly Dividend

Dynacor Declares December 2022 Monthly Dividend

MONTREAL, Nov. 28, 2022 (GLOBE NEWSWIRE) — Dynacor Group Inc. (TSX: DNG) (Dynacor or the Corporation) announced its monthly dividend. The declaration of a dividend payment of C$0.0083 per common share will be payable on December 19, 2022, to shareholders of record as of the close of business on December 9, 2022. This dividend represents the thirty third (33rd) dividend and twenty third (23rd) monthly payment made to shareholders. The Corporation’s monthly dividend qualifies as an “eligible dividend” for Canadian income tax purposes. The payment and increase of dividends are at the discretion of the Board and will depend on the Corporation’s financial results, cash requirements, prospects and other factors deemed relevant by the Board. ABOUT DYNACOR Dynacor is a dividend-paying industrial gold ore processor headquartered in Montreal,...

Continue reading

<div>GeoVax to Present at the World Vaccine & Immunotherapy Congress West Coast 2022</div>

GeoVax to Present at the World Vaccine & Immunotherapy Congress West Coast 2022

Presentation to Focus on Progress of Pan-Coronavirus (Universal) Vaccines to Protect Against Evolving Variants ATLANTA, GA, Nov. 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers, today announced that Mark J. Newman, Ph.D., Chief Scientific Officer of GeoVax, will present at the World Vaccine & Immunotherapy Congress (WVIC) West Coast 2022, taking place November 28-December 1, 2022, in San Diego, California. Dr. Newman will discuss the design and evaluation of MVA-vectored vaccines against betacoronaviruses and GeoVax’s progress toward producing vaccines that are more potent, induce broader immune responses, function in immunocompromised patients and individuals underserved by existing...

Continue reading

Regenx Grants Stock Options

Regenx Grants Stock Options

EDMONTON, Alberta, Nov. 28, 2022 (GLOBE NEWSWIRE) — Regenx Tech Corp., (the “Company” or “Regenx“) (TSXV: RGX) (OTCQB: RGXTF) (FSE: YRS WKN: A2DSW3) announces the Company has granted an aggregate of 3,900,000 stock options to directors, officers, employees, and various consultants of the Company. The options are at an exercise price of $0.05 per share and valid for a period of five years from the date of the grant, subject to vesting provisions. The options are granted in accordance with the Company’s Stock Option Plan approved by the shareholders on July 27, 2022. The grant of the options has been approved by the Board of Directors and is subject to the final approval of the TSX Venture Exchange. About Regenx Regenx is positioned for growth in the CleanTech sector through the development and commercialization...

Continue reading

Sp Mortgage Bank Plc and Oma Savings Bank Plc have signed an agreement on selling mortgages originated by Lieto Savings Bank to Oma Savings Bank

Sp Mortgage Bank Plc and Oma Savings Bank Plc have signed an agreement on selling mortgages originated by Lieto Savings Bank to Oma Savings Bank

Stock Exchange Release 28th of November 2022 at 5 pm (CET +1) Sp Mortgage Bank Plc and Oma Savings Bank Plc have 28.11.2022 signed an agreement on selling the mortgages originated by Lieto Savings Bank and currently held by Sp Mortgage Bank Plc to Oma savings Bank Plc. The signed agreement is part of a wider set of transactions whereby Lieto Savings Bank will sell its entire banking business to Oma Savings Bank plc.  The mortgages to be sold by Sp Mortgage Bank Plc to Oma Savings Bank Plc amount to roughly EUR 250 mio as per November 22nd 2022. After the sale Oma Savings Bank Plc carries all rights and responsibilities relating to the mortgages. The final volume of the mortgages subject to the transaction will be determined by the time the mortgages will be transferred to Oma Savings Bank. Further information: Karri Alameri, Managing Director,...

Continue reading

<div>Aktia Bank Plc - Managers' transactions – Anssi Huhta</div>

Aktia Bank Plc – Managers’ transactions – Anssi Huhta

Aktia Bank PlcStock Exchange Release28 November 2022 at 05.00 p.m. Aktia Bank Plc – Managers’ transactions – Anssi Huhta____________________________________________ Person subject to the notification requirementName: Huhta, AnssiPosition: Other senior managerIssuer: Aktia Bank plcLEI: 743700GC62JLHFBUND16 Notification type: INITIAL NOTIFICATIONReference number: 743700GC62JLHFBUND16_20221125103902_116____________________________________________ Transaction date: 2022-11-24Venue not applicableInstrument type: SHAREISIN: FI4000058870Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 822 Unit price: 0.00 EUR Aggregated transactions(1): Volume: 822 Volume weighted average price: 0.00 EUR AKTIA BANK PLC For more information:Ari Syrjäläinen, General Counsel, tel. +358 50 362 9587 Distribution:Nasdaq...

Continue reading

<div>Aktia Bank Plc - Managers' transactions – Outi Henriksson</div>

Aktia Bank Plc – Managers’ transactions – Outi Henriksson

Aktia Bank PlcStock Exchange Release28 November 2022 at 05.00 p.m. Aktia Bank Plc – Managers’ transactions – Outi Henriksson____________________________________________ Person subject to the notification requirementName: Henriksson, OutiPosition: Chief Financial OfficerIssuer: Aktia Bank plcLEI: 743700GC62JLHFBUND16 Notification type: INITIAL NOTIFICATIONReference number: 743700GC62JLHFBUND16_20221125103902_115____________________________________________ Transaction date: 2022-11-24Venue not applicableInstrument type: SHAREISIN: FI4000058870Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 551 Unit price: 0.00 EUR Aggregated transactions(1): Volume: 551 Volume weighted average price: 0.00 EUR AKTIA BANK PLC For more information:Ari Syrjäläinen, General Counsel, tel. +358 50 362 9587 Distribution:Nasdaq...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.